Global Restless Legs Syndrome Market Research Report 2023

Restless legs syndrome (RLS) is a neurological disease. RLS is also called as Willis-Ekbom disease. Patients suffering from RLS disease have an irresistible desire to move their feet. The continual movement of the legs leads to pain in the limbs, which leads to the unusual sleep pattern of patients.

The global Restless Legs Syndrome market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global key players of Restless Legs Syndrome include Boehringer Ingelheim GmbH, UCB SA, Astellas, Arbor Pharmaceuticals, etc.

Boehringer Ingelheim GmbH is the largest manufacturers of Restless Legs Syndrome in the world, has a share about 70%.

This report aims to provide a comprehensive presentation of the global market for Restless Legs Syndrome, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Restless Legs Syndrome.

The Restless Legs Syndrome market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Restless Legs Syndrome market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Restless Legs Syndrome companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Restless Legs Syndrome Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Pharmacological Therapy

1.2.3 Non-Pharmacological Therapy

1.3 Market by Application

1.3.1 Global Restless Legs Syndrome Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Below 35 Years Old

1.3.3 From 35 to 50 Years Old

1.3.4 Above 50 Years Old

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Restless Legs Syndrome Market Perspective (2018-2029)

2.2 Restless Legs Syndrome Growth Trends by Region

2.2.1 Global Restless Legs Syndrome Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Restless Legs Syndrome Historic Market Size by Region (2018-2023)

2.2.3 Restless Legs Syndrome Forecasted Market Size by Region (2024-2029)

2.3 Restless Legs Syndrome Market Dynamics

2.3.1 Restless Legs Syndrome Industry Trends

2.3.2 Restless Legs Syndrome Market Drivers

2.3.3 Restless Legs Syndrome Market Challenges

2.3.4 Restless Legs Syndrome Market Restraints

3.1 Global Top Restless Legs Syndrome Players by Revenue

3.1.1 Global Top Restless Legs Syndrome Players by Revenue (2018-2023)

3.1.2 Global Restless Legs Syndrome Revenue Market Share by Players (2018-2023)

3.2 Global Restless Legs Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Restless Legs Syndrome Revenue

3.4 Global Restless Legs Syndrome Market Concentration Ratio

3.4.1 Global Restless Legs Syndrome Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Restless Legs Syndrome Revenue in 2022

3.5 Restless Legs Syndrome Key Players Head office and Area Served

3.6 Key Players Restless Legs Syndrome Product Solution and Service

3.7 Date of Enter into Restless Legs Syndrome Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Restless Legs Syndrome Historic Market Size by Type (2018-2023)

4.2 Global Restless Legs Syndrome Forecasted Market Size by Type (2024-2029)

5.1 Global Restless Legs Syndrome Historic Market Size by Application (2018-2023)

5.2 Global Restless Legs Syndrome Forecasted Market Size by Application (2024-2029)

6.1 North America Restless Legs Syndrome Market Size (2018-2029)

6.2 North America Restless Legs Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Restless Legs Syndrome Market Size by Country (2018-2023)

6.4 North America Restless Legs Syndrome Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Restless Legs Syndrome Market Size (2018-2029)

7.2 Europe Restless Legs Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Restless Legs Syndrome Market Size by Country (2018-2023)

7.4 Europe Restless Legs Syndrome Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Restless Legs Syndrome Market Size (2018-2029)

8.2 Asia-Pacific Restless Legs Syndrome Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Restless Legs Syndrome Market Size by Region (2018-2023)

8.4 Asia-Pacific Restless Legs Syndrome Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Restless Legs Syndrome Market Size (2018-2029)

9.2 Latin America Restless Legs Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Restless Legs Syndrome Market Size by Country (2018-2023)

9.4 Latin America Restless Legs Syndrome Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Restless Legs Syndrome Market Size (2018-2029)

10.2 Middle East & Africa Restless Legs Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Restless Legs Syndrome Market Size by Country (2018-2023)

10.4 Middle East & Africa Restless Legs Syndrome Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Boehringer Ingelheim GmbH

11.1.1 Boehringer Ingelheim GmbH Company Detail

11.1.2 Boehringer Ingelheim GmbH Business Overview

11.1.3 Boehringer Ingelheim GmbH Restless Legs Syndrome Introduction

11.1.4 Boehringer Ingelheim GmbH Revenue in Restless Legs Syndrome Business (2018-2023)

11.1.5 Boehringer Ingelheim GmbH Recent Development

11.2 UCB SA

11.2.1 UCB SA Company Detail

11.2.2 UCB SA Business Overview

11.2.3 UCB SA Restless Legs Syndrome Introduction

11.2.4 UCB SA Revenue in Restless Legs Syndrome Business (2018-2023)

11.2.5 UCB SA Recent Development

11.3 Astellas

11.3.1 Astellas Company Detail

11.3.2 Astellas Business Overview

11.3.3 Astellas Restless Legs Syndrome Introduction

11.3.4 Astellas Revenue in Restless Legs Syndrome Business (2018-2023)

11.3.5 Astellas Recent Development

11.4 Arbor Pharmaceuticals

11.4.1 Arbor Pharmaceuticals Company Detail

11.4.2 Arbor Pharmaceuticals Business Overview

11.4.3 Arbor Pharmaceuticals Restless Legs Syndrome Introduction

11.4.4 Arbor Pharmaceuticals Revenue in Restless Legs Syndrome Business (2018-2023)

11.4.5 Arbor Pharmaceuticals Recent Development

11.5 GlaxoSmithKline plc.

11.5.1 GlaxoSmithKline plc. Company Detail

11.5.2 GlaxoSmithKline plc. Business Overview

11.5.3 GlaxoSmithKline plc. Restless Legs Syndrome Introduction

11.5.4 GlaxoSmithKline plc. Revenue in Restless Legs Syndrome Business (2018-2023)

11.5.5 GlaxoSmithKline plc. Recent Development

11.6 Ligand Pharmaceuticals Incorporated

11.6.1 Ligand Pharmaceuticals Incorporated Company Detail

11.6.2 Ligand Pharmaceuticals Incorporated Business Overview

11.6.3 Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Introduction

11.6.4 Ligand Pharmaceuticals Incorporated Revenue in Restless Legs Syndrome Business (2018-2023)

11.6.5 Ligand Pharmaceuticals Incorporated Recent Development

11.7 axxonis Pharma AG

11.7.1 axxonis Pharma AG Company Detail

11.7.2 axxonis Pharma AG Business Overview

11.7.3 axxonis Pharma AG Restless Legs Syndrome Introduction

11.7.4 axxonis Pharma AG Revenue in Restless Legs Syndrome Business (2018-2023)

11.7.5 axxonis Pharma AG Recent Development

11.8 Kyowa Hakko Kirin Co.

11.8.1 Kyowa Hakko Kirin Co. Company Detail

11.8.2 Kyowa Hakko Kirin Co. Business Overview

11.8.3 Kyowa Hakko Kirin Co. Restless Legs Syndrome Introduction

11.8.4 Kyowa Hakko Kirin Co. Revenue in Restless Legs Syndrome Business (2018-2023)

11.8.5 Kyowa Hakko Kirin Co. Recent Development

11.9 Jazz Pharmaceuticals, Inc.

11.9.1 Jazz Pharmaceuticals, Inc. Company Detail

11.9.2 Jazz Pharmaceuticals, Inc. Business Overview

11.9.3 Jazz Pharmaceuticals, Inc. Restless Legs Syndrome Introduction

11.9.4 Jazz Pharmaceuticals, Inc. Revenue in Restless Legs Syndrome Business (2018-2023)

11.9.5 Jazz Pharmaceuticals, Inc. Recent Development

11.10 Omeros Corporation

11.10.1 Omeros Corporation Company Detail

11.10.2 Omeros Corporation Business Overview

11.10.3 Omeros Corporation Restless Legs Syndrome Introduction

11.10.4 Omeros Corporation Revenue in Restless Legs Syndrome Business (2018-2023)

11.10.5 Omeros Corporation Recent Development

11.11 Manhattan Pharmaceuticals

11.11.1 Manhattan Pharmaceuticals Company Detail

11.11.2 Manhattan Pharmaceuticals Business Overview

11.11.3 Manhattan Pharmaceuticals Restless Legs Syndrome Introduction

11.11.4 Manhattan Pharmaceuticals Revenue in Restless Legs Syndrome Business (2018-2023)

11.11.5 Manhattan Pharmaceuticals Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Restless Legs Syndrome Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Pharmacological Therapy

    Table 3. Key Players of Non-Pharmacological Therapy

    Table 4. Global Restless Legs Syndrome Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 5. Global Restless Legs Syndrome Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Restless Legs Syndrome Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global Restless Legs Syndrome Market Share by Region (2018-2023)

    Table 8. Global Restless Legs Syndrome Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global Restless Legs Syndrome Market Share by Region (2024-2029)

    Table 10. Restless Legs Syndrome Market Trends

    Table 11. Restless Legs Syndrome Market Drivers

    Table 12. Restless Legs Syndrome Market Challenges

    Table 13. Restless Legs Syndrome Market Restraints

    Table 14. Global Restless Legs Syndrome Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global Restless Legs Syndrome Market Share by Players (2018-2023)

    Table 16. Global Top Restless Legs Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Restless Legs Syndrome as of 2022)

    Table 17. Ranking of Global Top Restless Legs Syndrome Companies by Revenue (US$ Million) in 2022

    Table 18. Global 5 Largest Players Market Share by Restless Legs Syndrome Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Restless Legs Syndrome Product Solution and Service

    Table 21. Date of Enter into Restless Legs Syndrome Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Restless Legs Syndrome Market Size by Type (2018-2023) & (US$ Million)

    Table 24. Global Restless Legs Syndrome Revenue Market Share by Type (2018-2023)

    Table 25. Global Restless Legs Syndrome Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 26. Global Restless Legs Syndrome Revenue Market Share by Type (2024-2029)

    Table 27. Global Restless Legs Syndrome Market Size by Application (2018-2023) & (US$ Million)

    Table 28. Global Restless Legs Syndrome Revenue Market Share by Application (2018-2023)

    Table 29. Global Restless Legs Syndrome Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 30. Global Restless Legs Syndrome Revenue Market Share by Application (2024-2029)

    Table 31. North America Restless Legs Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 32. North America Restless Legs Syndrome Market Size by Country (2018-2023) & (US$ Million)

    Table 33. North America Restless Legs Syndrome Market Size by Country (2024-2029) & (US$ Million)

    Table 34. Europe Restless Legs Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. Europe Restless Legs Syndrome Market Size by Country (2018-2023) & (US$ Million)

    Table 36. Europe Restless Legs Syndrome Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Asia-Pacific Restless Legs Syndrome Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Asia-Pacific Restless Legs Syndrome Market Size by Region (2018-2023) & (US$ Million)

    Table 39. Asia-Pacific Restless Legs Syndrome Market Size by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Restless Legs Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Latin America Restless Legs Syndrome Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Latin America Restless Legs Syndrome Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Middle East & Africa Restless Legs Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Middle East & Africa Restless Legs Syndrome Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Middle East & Africa Restless Legs Syndrome Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Boehringer Ingelheim GmbH Company Detail

    Table 47. Boehringer Ingelheim GmbH Business Overview

    Table 48. Boehringer Ingelheim GmbH Restless Legs Syndrome Product

    Table 49. Boehringer Ingelheim GmbH Revenue in Restless Legs Syndrome Business (2018-2023) & (US$ Million)

    Table 50. Boehringer Ingelheim GmbH Recent Development

    Table 51. UCB SA Company Detail

    Table 52. UCB SA Business Overview

    Table 53. UCB SA Restless Legs Syndrome Product

    Table 54. UCB SA Revenue in Restless Legs Syndrome Business (2018-2023) & (US$ Million)

    Table 55. UCB SA Recent Development

    Table 56. Astellas Company Detail

    Table 57. Astellas Business Overview

    Table 58. Astellas Restless Legs Syndrome Product

    Table 59. Astellas Revenue in Restless Legs Syndrome Business (2018-2023) & (US$ Million)

    Table 60. Astellas Recent Development

    Table 61. Arbor Pharmaceuticals Company Detail

    Table 62. Arbor Pharmaceuticals Business Overview

    Table 63. Arbor Pharmaceuticals Restless Legs Syndrome Product

    Table 64. Arbor Pharmaceuticals Revenue in Restless Legs Syndrome Business (2018-2023) & (US$ Million)

    Table 65. Arbor Pharmaceuticals Recent Development

    Table 66. GlaxoSmithKline plc. Company Detail

    Table 67. GlaxoSmithKline plc. Business Overview

    Table 68. GlaxoSmithKline plc. Restless Legs Syndrome Product

    Table 69. GlaxoSmithKline plc. Revenue in Restless Legs Syndrome Business (2018-2023) & (US$ Million)

    Table 70. GlaxoSmithKline plc. Recent Development

    Table 71. Ligand Pharmaceuticals Incorporated Company Detail

    Table 72. Ligand Pharmaceuticals Incorporated Business Overview

    Table 73. Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Product

    Table 74. Ligand Pharmaceuticals Incorporated Revenue in Restless Legs Syndrome Business (2018-2023) & (US$ Million)

    Table 75. Ligand Pharmaceuticals Incorporated Recent Development

    Table 76. axxonis Pharma AG Company Detail

    Table 77. axxonis Pharma AG Business Overview

    Table 78. axxonis Pharma AG Restless Legs Syndrome Product

    Table 79. axxonis Pharma AG Revenue in Restless Legs Syndrome Business (2018-2023) & (US$ Million)

    Table 80. axxonis Pharma AG Recent Development

    Table 81. Kyowa Hakko Kirin Co. Company Detail

    Table 82. Kyowa Hakko Kirin Co. Business Overview

    Table 83. Kyowa Hakko Kirin Co. Restless Legs Syndrome Product

    Table 84. Kyowa Hakko Kirin Co. Revenue in Restless Legs Syndrome Business (2018-2023) & (US$ Million)

    Table 85. Kyowa Hakko Kirin Co. Recent Development

    Table 86. Jazz Pharmaceuticals, Inc. Company Detail

    Table 87. Jazz Pharmaceuticals, Inc. Business Overview

    Table 88. Jazz Pharmaceuticals, Inc. Restless Legs Syndrome Product

    Table 89. Jazz Pharmaceuticals, Inc. Revenue in Restless Legs Syndrome Business (2018-2023) & (US$ Million)

    Table 90. Jazz Pharmaceuticals, Inc. Recent Development

    Table 91. Omeros Corporation Company Detail

    Table 92. Omeros Corporation Business Overview

    Table 93. Omeros Corporation Restless Legs Syndrome Product

    Table 94. Omeros Corporation Revenue in Restless Legs Syndrome Business (2018-2023) & (US$ Million)

    Table 95. Omeros Corporation Recent Development

    Table 96. Manhattan Pharmaceuticals Company Detail

    Table 97. Manhattan Pharmaceuticals Business Overview

    Table 98. Manhattan Pharmaceuticals Restless Legs Syndrome Product

    Table 99. Manhattan Pharmaceuticals Revenue in Restless Legs Syndrome Business (2018-2023) & (US$ Million)

    Table 100. Manhattan Pharmaceuticals Recent Development

    Table 101. Research Programs/Design for This Report

    Table 102. Key Data Information from Secondary Sources

    Table 103. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Restless Legs Syndrome Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Restless Legs Syndrome Market Share by Type: 2022 VS 2029

    Figure 3. Pharmacological Therapy Features

    Figure 4. Non-Pharmacological Therapy Features

    Figure 5. Global Restless Legs Syndrome Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 6. Global Restless Legs Syndrome Market Share by Application: 2022 VS 2029

    Figure 7. Below 35 Years Old Case Studies

    Figure 8. From 35 to 50 Years Old Case Studies

    Figure 9. Above 50 Years Old Case Studies

    Figure 10. Restless Legs Syndrome Report Years Considered

    Figure 11. Global Restless Legs Syndrome Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 12. Global Restless Legs Syndrome Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 13. Global Restless Legs Syndrome Market Share by Region: 2022 VS 2029

    Figure 14. Global Restless Legs Syndrome Market Share by Players in 2022

    Figure 15. Global Top Restless Legs Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Restless Legs Syndrome as of 2022)

    Figure 16. The Top 10 and 5 Players Market Share by Restless Legs Syndrome Revenue in 2022

    Figure 17. North America Restless Legs Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 18. North America Restless Legs Syndrome Market Share by Country (2018-2029)

    Figure 19. United States Restless Legs Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. Canada Restless Legs Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Europe Restless Legs Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Restless Legs Syndrome Market Share by Country (2018-2029)

    Figure 23. Germany Restless Legs Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. France Restless Legs Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. U.K. Restless Legs Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Italy Restless Legs Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Russia Restless Legs Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Nordic Countries Restless Legs Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Asia-Pacific Restless Legs Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Restless Legs Syndrome Market Share by Region (2018-2029)

    Figure 31. China Restless Legs Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Japan Restless Legs Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. South Korea Restless Legs Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Southeast Asia Restless Legs Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. India Restless Legs Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Australia Restless Legs Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Latin America Restless Legs Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Restless Legs Syndrome Market Share by Country (2018-2029)

    Figure 39. Mexico Restless Legs Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Brazil Restless Legs Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Middle East & Africa Restless Legs Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Restless Legs Syndrome Market Share by Country (2018-2029)

    Figure 43. Turkey Restless Legs Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Saudi Arabia Restless Legs Syndrome Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Boehringer Ingelheim GmbH Revenue Growth Rate in Restless Legs Syndrome Business (2018-2023)

    Figure 46. UCB SA Revenue Growth Rate in Restless Legs Syndrome Business (2018-2023)

    Figure 47. Astellas Revenue Growth Rate in Restless Legs Syndrome Business (2018-2023)

    Figure 48. Arbor Pharmaceuticals Revenue Growth Rate in Restless Legs Syndrome Business (2018-2023)

    Figure 49. GlaxoSmithKline plc. Revenue Growth Rate in Restless Legs Syndrome Business (2018-2023)

    Figure 50. Ligand Pharmaceuticals Incorporated Revenue Growth Rate in Restless Legs Syndrome Business (2018-2023)

    Figure 51. axxonis Pharma AG Revenue Growth Rate in Restless Legs Syndrome Business (2018-2023)

    Figure 52. Kyowa Hakko Kirin Co. Revenue Growth Rate in Restless Legs Syndrome Business (2018-2023)

    Figure 53. Jazz Pharmaceuticals, Inc. Revenue Growth Rate in Restless Legs Syndrome Business (2018-2023)

    Figure 54. Omeros Corporation Revenue Growth Rate in Restless Legs Syndrome Business (2018-2023)

    Figure 55. Manhattan Pharmaceuticals Revenue Growth Rate in Restless Legs Syndrome Business (2018-2023)

    Figure 56. Bottom-up and Top-down Approaches for This Report

    Figure 57. Data Triangulation

    Figure 58. Key Executives Interviewed